270 related articles for article (PubMed ID: 30592434)
21. Inverse correlation between Ink4-locus deletions and ICM-DNA hyperdiploidy in childhood acute lymphoblastic leukaemia, relation to clinical characteristics and outcome.
Moreno TC; Widell S; Czader M; Grandér D; Söderhäll S; Gustafsson G; Einhorn S; Porwit A; Heyman M
Eur J Haematol; 2000 Dec; 65(6):390-8. PubMed ID: 11168496
[TBL] [Abstract][Full Text] [Related]
22. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
[TBL] [Abstract][Full Text] [Related]
23. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
24. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
Boldrin E; Gaffo E; Niedermayer A; Boer JM; Zimmermann M; Weichenhan D; Claus R; Münch V; Sun Q; Enzenmüller S; Seyfried F; Demir S; Zinngrebe J; Cario G; Schrappe M; Den Boer ML; Plass C; Debatin KM; Te Kronnie G; Bortoluzzi S; Meyer LH
Blood; 2021 Nov; 138(20):1953-1965. PubMed ID: 34098582
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia.
Wang Y; Chen G; Cao R; Li J; He L; Guo X; Liang J; Shi P; Zhou Y; Xu B
Pharmacogenomics; 2017 Jan; 18(1):77-84. PubMed ID: 27967319
[TBL] [Abstract][Full Text] [Related]
27. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
Zhou M; Gu L; Yeager AM; Findley HW
Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
[TBL] [Abstract][Full Text] [Related]
28. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.
Jia M; Wang ZJ; Li JY; Yang SL; Zhao HZ; Cheng YP; Luo ZB; Tang YM
Cancer Biomark; 2014; 14(6):493-503. PubMed ID: 25335741
[TBL] [Abstract][Full Text] [Related]
29. The Yin and Yang-Like Clinical Implications of the
González-Gil C; Ribera J; Ribera JM; Genescà E
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of CDKN2A, CDKN2B and MTAP in childhood B-lineage acute lymphobastic leukemia.
Beverloo HB
Haematologica; 2006 Jul; 91(7):865B. PubMed ID: 16818264
[No Abstract] [Full Text] [Related]
31. Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
Zhang W; Jang E
PLoS One; 2021; 16(8):e0256801. PubMed ID: 34437635
[TBL] [Abstract][Full Text] [Related]
32. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
[TBL] [Abstract][Full Text] [Related]
33. The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia.
Carrasco Salas P; Fernández L; Vela M; Bueno D; González B; Valentín J; Lapunzina P; Pérez-Martínez A
Pediatr Hematol Oncol; 2016; 33(7-8):415-422. PubMed ID: 27960642
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis.
Jia M; Wang ZJ; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Tang YM
World J Pediatr; 2015 May; 11(2):126-33. PubMed ID: 25920591
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
36. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
[TBL] [Abstract][Full Text] [Related]
37. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications.
Wong IH; Ng MH; Huang DP; Lee JC
Blood; 2000 Mar; 95(6):1942-9. PubMed ID: 10706859
[TBL] [Abstract][Full Text] [Related]
38. The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor.
Hoshino K; Asou N; Okubo T; Suzushima H; Kiyokawa T; Kawano F; Mitsuya H
Br J Haematol; 2002 Jun; 117(3):531-40. PubMed ID: 12028019
[TBL] [Abstract][Full Text] [Related]
39. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
40. Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.
Novara F; Beri S; Bernardo ME; Bellazzi R; Malovini A; Ciccone R; Cometa AM; Locatelli F; Giorda R; Zuffardi O
Hum Genet; 2009 Oct; 126(4):511-20. PubMed ID: 19484265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]